Literature DB >> 16081417

WNK1 activates SGK1 by a phosphatidylinositol 3-kinase-dependent and non-catalytic mechanism.

Bing-E Xu1, Steve Stippec, Ahmed Lazrak, Chou-Long Huang, Melanie H Cobb.   

Abstract

WNK1 (with no lysine (K) 1) is a protein-serine/threonine kinase with a unique catalytic site organization. Deletions in the first intron of the WNK1 gene were found in a group of hypertensive patients with pseudohypoaldosteronism type II. No changes in coding sequence of WNK1 were found, but its expression was increased severalfold. We have been investigating actions of WNK1 and have found that WNK1 activates the serum- and glucocorticoid-induced protein kinase SGK1, which impacts membrane expression of the epithelial sodium channel. Here we explore the role of WNK1 in SGK1 regulation. Activation of SGK1 by WNK1 is blocked by phosphatidylinositol 3-kinase inhibitors. Neither the catalytic activity nor the kinase domain of WNK1 is required; rather the N-terminal 220 residues of WNK1 are necessary and sufficient to activate SGK1. Phosphorylation of WNK1 on Thr-58 contributes to SGK1 activation. Finally, we show that WNK1 is required for the activation of SGK1 by insulin-like growth factor 1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081417     DOI: 10.1074/jbc.M505735200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Multigene kinase network, kidney transport, and salt in essential hypertension.

Authors:  Paul A Welling; Yen-Pei C Chang; Eric Delpire; James B Wade
Journal:  Kidney Int       Date:  2010-04-14       Impact factor: 10.612

2.  WNK lies upstream of kinases involved in regulation of ion transporters.

Authors:  Gerardo Gamba
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

3.  WNK3 bypasses the tonicity requirement for K-Cl cotransporter activation via a phosphatase-dependent pathway.

Authors:  Paola de Los Heros; Kristopher T Kahle; Jesse Rinehart; Norma A Bobadilla; Norma Vázquez; Pedro San Cristobal; David B Mount; Richard P Lifton; Steven C Hebert; Gerardo Gamba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

Review 4.  Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome.

Authors:  Jian Xie; Leonard Craig; Melanie H Cobb; Chou-Long Huang
Journal:  Pediatr Nephrol       Date:  2006-05-09       Impact factor: 3.714

Review 5.  WNK kinases and renal sodium transport in health and disease: an integrated view.

Authors:  James A McCormick; Chao-Ling Yang; David H Ellison
Journal:  Hypertension       Date:  2008-01-22       Impact factor: 10.190

Review 6.  Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC).

Authors:  Johannes Loffing; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2009-03-11       Impact factor: 3.657

7.  WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway.

Authors:  Wei Zhang; Tao Na; Ji-Bin Peng
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-03

Review 8.  WNK kinases and blood pressure control.

Authors:  Staci L Deaton; Samarpita Sengupta; Melanie H Cobb
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

9.  Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.

Authors:  Chibo Hong; K Scott Moorefield; Peter Jun; Kenneth D Aldape; Samir Kharbanda; Heidi S Phillips; Joseph F Costello
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

10.  Chloride sensing by WNK1 involves inhibition of autophosphorylation.

Authors:  Alexander T Piala; Thomas M Moon; Radha Akella; Haixia He; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.